Long-Term Efficacy of Psoralen Plus Ultraviolet a Irradiation and Low-Dose Interferon-Alpha Therapy According to Conventional and Emerging Clinical Endopoints of Early Stage Cutaneous T Cell Lymphoma / Rupoli, S., Goteri, G., Morsia, E., Torre, E., Garvey, K.b., Giantomassi, F., Campanati, A., Offidani, A.m., Brandozzi, G., Giorgio, M., Simonacci, M., Olivieri, A.. - In: BLOOD. - ISSN 0006-4971. - 138:(2021), pp. 2462-2462. [10.1182/blood-2021-150633]
Long-Term Efficacy of Psoralen Plus Ultraviolet a Irradiation and Low-Dose Interferon-Alpha Therapy According to Conventional and Emerging Clinical Endopoints of Early Stage Cutaneous T Cell Lymphoma
Rupoli, SPrimo
;Goteri, G;Morsia, E
;Torre, E;Garvey, KB;Giantomassi, F;Campanati, A;Offidani, AM;Olivieri, A
2021-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
